KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Asset Writedowns and Impairment (2016 - 2025)

Globus Medical (GMED) has disclosed Asset Writedowns and Impairment for 15 consecutive years, with $16.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Writedowns and Impairment rose 134.58% year-over-year to $16.8 million, compared with a TTM value of $22.1 million through Dec 2025, down 5.31%, and an annual FY2025 reading of $22.1 million, down 5.31% over the prior year.
  • Asset Writedowns and Impairment was $16.8 million for Q4 2025 at Globus Medical, up from -$5.6 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $16.8 million in Q4 2025 and bottomed at -$5.9 million in Q4 2022.
  • Average Asset Writedowns and Impairment over 5 years is $2.9 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Asset Writedowns and Impairment crashed 1958.36% in 2022, then soared 383.21% in 2024.
  • Year by year, Asset Writedowns and Impairment stood at $317000.0 in 2021, then plummeted by 1958.36% to -$5.9 million in 2022, then surged by 172.3% to $4.3 million in 2023, then skyrocketed by 68.23% to $7.2 million in 2024, then skyrocketed by 134.58% to $16.8 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for GMED at $16.8 million in Q4 2025, -$5.6 million in Q3 2025, and $7.7 million in Q2 2025.